申请人:Plexxikon Inc.
公开号:US20170157120A1
公开(公告)日:2017-06-08
Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
描述了对蛋白激酶活性有影响的化合物,以及制备和使用这些化合物来治疗与蛋白激酶异常活性相关的疾病和症状的方法。